A recent report identified COL3A1 in a 7-gene signature related to stage in SC patients contributing to extracellular matrix interactions and mitosis [41], supporting our findings that COL3A1 may be a promising prognostic factor for ovarian tumor progression. This evidence concerns the gene COL3A1 and ovarian neoplasm.